Research Peptide Companies Also Bite Into GLP-1 Pie Manufacturers of research peptides are also selling unbranded versions of weight loss drugs, such as unlicensed versions of semaglutide and tirzepatide, the active ingredients in Novos and Lillys drugs, respectively
Production scalability is another critical aspect that many early-stage brands overlook
Ildong Pharmaceutical is researching an orally administered GLP-1 class candidate as a treatment for obesity and metabolic diseases
However, clinical trials are warranted to translate the promising preclinical findings into viable therapeutic approaches for TBI patients
Miscalculate your dosage, and you could waste product, delay recovery, or experience diminished effects
However, the high costs of GLP-1s, which can go for upward of around $1,070, and SGLT-2sthe most common SGLT-2 costs around $650may be a significant barrier in providing patients with access to treatment, according to an accompanying editorial by Fatima Zyed, an internal medicine doctor at Duke Universitys Division of General Internal Medicine